PROGNOSTIC SIGNIFICANCE OF REARRANGEMENTS OF EML4-ALK IN PATIENTS WITH STAGE TI-II ADENOCARCINOMA IN THE RELATIONSHIP WITH SOME CLINICAL AND MORPHOLOGICAL PARAMETERS
- Authors: Avdalyan A.M.1, Panasyan A.U1, Ivanov A.A1, Samuilenkova O.V2, Bakharev S.Y2, Bliznyuk A.S2, Lazarev A.F.1
-
Affiliations:
- Altai Branch of the N.N. Blokhin Russian Cancer Research Center
- Altai Krai Oncology Centre
- Issue: Vol 22, No 4 (2017)
- Pages: 194-197
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40372
- DOI: https://doi.org/10.18821/1028-9984-2017-22-4-194-197
- ID: 40372
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Ashot M. Avdalyan
Altai Branch of the N.N. Blokhin Russian Cancer Research Center
Email: ashot_avdalyan@mail.ru
MD, PhD, DSc, Senior Researcher of the Laboratory of Investigations of Molecular Genetic Characteristics of Tumors of the Altai Branch of the N.N. Blokhin Russian Cancer Research Center; Barnaul, 656049, Russian Federation Barnaul, 656049, Russian Federation
A. U Panasyan
Altai Branch of the N.N. Blokhin Russian Cancer Research CenterBarnaul, 656049, Russian Federation
A. A Ivanov
Altai Branch of the N.N. Blokhin Russian Cancer Research CenterBarnaul, 656049, Russian Federation
O. V Samuilenkova
Altai Krai Oncology CentreBarnaul, 656043, Russian Federation
S. Y Bakharev
Altai Krai Oncology CentreBarnaul, 656043, Russian Federation
A. S Bliznyuk
Altai Krai Oncology CentreBarnaul, 656043, Russian Federation
A. F.I Lazarev
Altai Branch of the N.N. Blokhin Russian Cancer Research CenterBarnaul, 656049, Russian Federation
References
- Lee J.K., Park H.S., Kim D.W. et al. Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer. Cancer. 2012; 118: 3579-86.
- Soda M., Choi Y.L., Enomoto M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007; 448: 561-6.
- Al-Saad S., Al-Shibli K., Donnem T., Andersen S., Bremnes R.M., Busund L.T. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients. J. Thorac. Oncol. 2010; 5: 1536-43.
- Kwak E.L., Bang Y.J., Camidge D.R. et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 2010; 363: 1693-703.
- Mino-Kenudson M., Chirieac L.R., Law K. et al. A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin. Cancer Res. 2010; 16: 1561-71.
- Demidova I., Grinevich V., Avdalian A. et al. Detection of ALK rearrangements in 4002 Russian patients: The utilityof different diagnostic approaches. Lung Cancer. 2017; 103: 17-23.
- Warth A., Penzel R., Lindenmaier H., Brandt R., Stenzinger A., Herpel E. et al. EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. Eur. Respir. J. 2014; 43: 872-3.
- Lee J.O., Kim T.M., Lee S.H. et al. Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer. J. Thorac. Oncol. 2011; 6: 1474-80.
- Nakamura H., Saji H., Ogata A., Hosaka M., Hagiwara M., Kawasaki N. et al. Correlation between encoded protein overexpression and copy number of the HER2 gene with survival in non-small cell lung cancer. Int. J. Cancer. 2003; 103: 61-6.